Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9


The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomics.

Jean Beltran PM, Cristea IM.

Expert Rev Proteomics. 2014 Dec;11(6):697-711. doi: 10.1586/14789450.2014.971116. Epub 2014 Oct 18.


Role of human cytomegalovirus tegument proteins in virion assembly.

Smith RM, Kosuri S, Kerry JA.

Viruses. 2014 Feb 6;6(2):582-605. doi: 10.3390/v6020582. Review.


Tale of a tegument transactivator: the past, present and future of human CMV pp71.

Penkert RR, Kalejta RF.

Future Virol. 2012 Sep 1;7(9):855-869.


Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

van Domselaar R, de Poot SA, Remmerswaal EB, Lai KW, ten Berge IJ, Bovenschen N.

Cell Death Differ. 2013 Mar;20(3):419-29. doi: 10.1038/cdd.2012.132. Epub 2012 Oct 26.


BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection.

Lee SH, Kalejta RF, Kerry J, Semmes OJ, O'Connor CM, Khan Z, Garcia BA, Shenk T, Murphy E.

Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9575-80. doi: 10.1073/pnas.1207496109. Epub 2012 May 29.


Functional properties of the human cytomegalovirus IE86 protein required for transcriptional regulation and virus replication.

Harris SM, Bullock B, Westgard E, Zhu H, Stenberg RM, Kerry JA.

J Virol. 2010 Sep;84(17):8839-48. doi: 10.1128/JVI.00327-10. Epub 2010 Jun 16.


Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.

Saffert RT, Penkert RR, Kalejta RF.

J Virol. 2010 Jun;84(11):5594-604. doi: 10.1128/JVI.00348-10. Epub 2010 Mar 24.


Properties of virion transactivator proteins encoded by primate cytomegaloviruses.

Nicholson IP, Sutherland JS, Chaudry TN, Blewett EL, Barry PA, Nicholl MJ, Preston CM.

Virol J. 2009 May 27;6:65. doi: 10.1186/1743-422X-6-65.

Supplemental Content

Support Center